Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 3817

1.

Incidence of community acquired pneumonia in children aged 2-59 months of age in Uttar Pradesh and Bihar, India, in 2016: An indirect estimation.

Awasthi S, Pandey CM, Verma T, Mishra N; Lucknow CAP Group.

PLoS One. 2019 Mar 20;14(3):e0214086. doi: 10.1371/journal.pone.0214086. eCollection 2019.

2.

Neutrophil-to-lymphocyte ratio as a serum biomarker associated with community acquired pneumonia

Che-Morales JL, Cortes-Telles A.

Rev Med Inst Mex Seguro Soc. 2019 Mar 15;56(6):537-543. Spanish.

PMID:
30889342
3.

The role of Endocan as a Prognostic Biomarker in community-acquired pneumonia.

Gunaydin S, Kucuk M, Gunaydin UM.

Pak J Med Sci. 2019 Jan-Feb;35(1):117-123. doi: 10.12669/pjms.35.1.280.

4.

Cytokines and Cortisol - predictors of treatment response to corticosteroids in community-acquired pneumonia?

Urwyler SA, Blum CA, Coslovsky M, Mueller B, Schuetz P, Christ-Crain M.

J Intern Med. 2019 Mar 14. doi: 10.1111/joim.12891. [Epub ahead of print]

PMID:
30873676
5.

Epidemiological, clinical, and microbiological characteristics of carbapenemase-producing Enterobacteriaceae bloodstream infection in the Republic of Korea.

Park JW, Lee H, Park SY, Kim TH.

Antimicrob Resist Infect Control. 2019 Mar 5;8:48. doi: 10.1186/s13756-019-0497-3. eCollection 2019.

6.

Inflammatory biomarkers are associated with aetiology and predict outcomes in community-acquired pneumonia: results of a 5-year follow-up cohort study.

Siljan WW, Holter JC, Michelsen AE, Nymo SH, Lauritzen T, Oppen K, Husebye E, Ueland T, Mollnes TE, Aukrust P, Heggelund L.

ERJ Open Res. 2019 Mar 11;5(1). pii: 00014-2019. doi: 10.1183/23120541.00014-2019. eCollection 2019 Feb.

7.

[Circular tracheal resection for acquired tracheal stenosis: evaluation of early and long-term outcomes].

Esakov YS, Pechetov AA, Khlan TN, Solodinina EN, Slepenkova KV, Bessonova SA, Lukich KV, Davydenko PI.

Khirurgiia (Mosk). 2019;(2):19-25. doi: 10.17116/hirurgia201902119. Russian.

PMID:
30855586
8.

C-reactive protein evaluation in communityacquired pneumonia with comorbid chronic heart failure as criterion of antibiotic prescription.

Bobylev AA, Rachina SA, Avdeev SN, Kozlov RS, Mladov VV.

Kardiologiia. 2019 Mar 7;59(2S):40-46. doi: 10.18087/cardio.2661. Russian.

PMID:
30853012
9.

[Features of community-acquired pneumonia in immunocompetent hospitalized adults according to the causal agent].

Saldias Peñafiel F, Gassmann Poniachik J, Canelo López A, Díaz Patiño O.

Rev Med Chil. 2018 Dec;146(12):1371-1383. doi: 10.4067/s0034-98872018001201371. Spanish.

10.

Necrotizing pneumonia (aetiology, clinical features and management).

Krutikov M, Rahman A, Tiberi S.

Curr Opin Pulm Med. 2019 Feb 26. doi: 10.1097/MCP.0000000000000571. [Epub ahead of print]

PMID:
30844921
11.

Identification of Burkholderia pseudomallei using the VITEK mass spectrometer.

Gassiep I, Armstrong M, Norton RE.

J Clin Microbiol. 2019 Mar 6. pii: JCM.00081-19. doi: 10.1128/JCM.00081-19. [Epub ahead of print]

PMID:
30842230
12.

Pneumonia severity index in viral community acquired pneumonia in adults.

Kim MA, Park JS, Lee CW, Choi WI.

PLoS One. 2019 Mar 6;14(3):e0210102. doi: 10.1371/journal.pone.0210102. eCollection 2019.

13.

Bacteremic Community-Acquired Pneumonia in Ethiopian Children: Etiology, Antibiotic Resistance, Risk Factors, and Clinical Outcome.

Negash AA, Asrat D, Abebe W, Hailemariam T, Hailu T, Aseffa A, Vaneechoutte M.

Open Forum Infect Dis. 2019 Jan 23;6(3):ofz029. doi: 10.1093/ofid/ofz029. eCollection 2019 Mar.

14.

Activation of the kynurenine pathway is associated with poor outcome in Pneumocystis pneumonia patients infected with HIV: results of 2 months cohort study.

Wang M, Dong X, Huang Y, Su J, Dai X, Guo Y, Hu C, Zhou Q, Zhu B.

BMC Infect Dis. 2019 Mar 4;19(1):223. doi: 10.1186/s12879-019-3851-4.

15.

Healthcare-asociated pneumonia:Any reasons to still utilize this label in 2019?

Ewig S, Kolditz M, Pletz MW, Chalmers J.

Clin Microbiol Infect. 2019 Feb 27. pii: S1198-743X(19)30090-4. doi: 10.1016/j.cmi.2019.02.022. [Epub ahead of print] Review.

PMID:
30825674
16.

Factors influencing mortality in hospital-acquired pneumonia caused by Gram-negative bacteria in China.

Feng DY, Zhou YQ, Zou XL, Zhou M, Wu WB, Chen XX, Wang YH, Zhang TT.

J Infect Public Health. 2019 Feb 26. pii: S1876-0341(19)30085-1. doi: 10.1016/j.jiph.2019.02.014. [Epub ahead of print]

17.

Influence of Obesity on Pneumococcus Infection Risk in the Elderly.

Frasca D, McElhaney J.

Front Endocrinol (Lausanne). 2019 Feb 13;10:71. doi: 10.3389/fendo.2019.00071. eCollection 2019. Review.

18.

Factors Associated with Mortality in Immunocompetent Patients with Hospital-acquired Pneumonia.

Sangmuang P, Lucksiri A, Katip W.

J Glob Infect Dis. 2019 Jan-Mar;11(1):13-18. doi: 10.4103/jgid.jgid_33_18.

19.

Solithromycin monotherapy for treatment of community-acquired bacterial pneumonia: A meta-analysis of randomised controlled trials.

Wen J, Chen F, Zhao M, Wang X.

Int J Clin Pract. 2019 Feb 27:e13333. doi: 10.1111/ijcp.13333. [Epub ahead of print]

PMID:
30810253
20.

Early improvement in severely ill patients with pneumonia treated with ceftobiprole: a retrospective analysis of two major trials.

Scheeren TWL, Welte T, Saulay M, Engelhardt M, Santerre-Henriksen A, Hamed K.

BMC Infect Dis. 2019 Feb 26;19(1):195. doi: 10.1186/s12879-019-3820-y.

Supplemental Content

Loading ...
Support Center